347 Results

People

  1. Mauro
    Mauro
  2. Clarkson
    Clarkson
  3. Berman
    Berman
  4. O'Reilly
    O'Reilly
  5. Strife
    Strife
  6. Wisniewski
    Wisniewski
  7. Kernan
    Kernan
  8. Sawyers
    Sawyers
  9. Scheinberg
    Scheinberg
  10. Papadopoulos
    Papadopoulos

Groups

  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)
  7. Tow Center for Developmental Oncology (TCDO) (77)
  8. Molecular Pharmacology and Chemistry Program Faculty (71)
  9. Human Oncology and Pathogenesis Program (47)
  10. Pediatrics, Department of (46)
  1. "chronic myeloid leukemia"
Formats
  1. Journal Article (300)
  2. Meeting Abstract (18)
  3. Review (10)
  4. Conference Paper (8)
  5. Research Letter (6)
  6. Correspondence (2)
  7. Editorial (2)
  8. Guidelines (1)
Groups
  1. Department of Medicine (242)
  2. Hematologic Malignancies, Division of (207)
  3. Center for Hematologic Malignancies (182)
  4. Adult Leukemia (117)
  5. Sloan Kettering Institute Faculty (108)
  6. GSK Faculty (106)

More Groups

People
  1. Michael Mauro (56)
  2. Bayard Clarkson (40)
  3. Ellin Berman (24)
  4. Annabel Strife (20)
  5. Richard O'Reilly (20)
  6. David Wisniewski (18)

More People

Years
  1. 2025 (7)
  2. 2024 (16)
  3. 2023 (20)
  4. 2022 (13)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Blood (29)
  2. Leukemia (23)
  3. Clinical Lymphoma, Myeloma and Leukemia (19)
  4. Biology of Blood and Marrow Transplantation (17)
  5. Bone Marrow Transplantation (15)
  6. Cancer Research (14)

More Publications

Publishers
  1. Elsevier Inc. (51)
  2. Nature Publishing Group (51)
  3. American Society of Hematology (33)
  4. American Association for Cancer Research (20)
  5. John Wiley & Sons (12)
  6. Springer (12)

More Publishers

Results (347)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Blood and Marrow Transplant Clinical Trials Network report on the development of novel endpoints and selection of promising approaches for graft-versus-host disease prevention trials
    Journal Article

    Pasquini, M. C.; Logan, B.; Jones, R. J.; Alousi, A. M.; Appelbaum, F. R.; Bolaños-Meade, J.; Flowers, M. E. D.; Giralt, S.; Horowitz, M. M.; Jacobsohn, D.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) with stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
    Meeting Abstract

    Shah, N. P.; Garcia-Gutierrez, J. V.; Jimenez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gomez-Casares, M. T.; Pane, F.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia
    Journal Article

    Atallah, E.; Schiffer, C. A.; Weinfurt, K. P.; Zhang, M. J.; Radich, J. P.; Oehler, V. G.; Pinilla-Ibarz, J.; Deininger, M. W. N.; Lin, L.; Larson, R. A.; more...
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • Considerations for successful treatment-free remission in chronic myeloid leukemia
    Journal Article

    Goldberg, S. L.; Savona, M.; Mauro, M. J.
    Clinical Lymphoma, Myeloma and Leukemia (2018)

    Fulltext@MSK | Save
  • Effects of late toxicities on outcomes in long-term survivors of ex-vivo CD34(+)-selected allogeneic hematopoietic cell transplantation
    Journal Article

    Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M. A.; Nieves, J.; Borrill, T.; Avecilla, S. T.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Prediction of absolute risk of acute graft-versus-host disease following hematopoietic cell transplantation
    Journal Article

    Lee, C.; Haneuse, S.; Wang, H. L.; Rose, S.; Spellman, S. R.; Verneris, M.; Hsu, K. C.; Fleischhauer, K.; Lee, S. J.; Abdi, R.
    PLoS ONE (2018)

    Fulltext@MSK | Save
  • Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: Results from the randomized BFORE trial
    Journal Article

    Cortes, J. E.; Gambacorti-Passerini, C.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; le Coutre, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • First-line treatment selection and early monitoring patterns in chronic phase-chronic myeloid leukemia in routine clinical practice: SIMPLICITY
    Journal Article

    Goldberg, S. L.; Cortes, J. E.; Gambacorti-Passerini, C.; Hehlmann, R.; Khoury, H. J.; Michallet, M.; Paquette, R. L.; Simonsson, B.; Zyczynski, T.; Foreman, A.; more...
    American Journal of Hematology (2017)

    Fulltext@MSK | Save
  • Diagnosis and classification of hematologic malignancies on the basis of genetics
    Journal Article

    Taylor, J.; Xiao, W.; Abdel-Wahab, O.
    Blood (2017)

    Fulltext@MSK | Save
  • Tyrosine kinase inhibitor treatment for newly diagnosed chronic myeloid leukemia
    Journal Article

    Radich, J. P.; Mauro, M. J.
    Hematology/Oncology Clinics of North America (2017)

    Fulltext@MSK | Save